M1FG
ELV icon

Mach-1 Financial Group’s Elevance Health ELV Stock Holding History

Mach-1 Financial Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,764
Closed -$832K – 125
2023
Q4 		$832K Sell
1,764
-2,887
-62% -$1.33M 0.32% 71
2023
Q3 		$2.02M Sell
4,651
-24
-0.5% -$10.9K 0.84% 31
2023
Q2 		$2.08M Buy
4,675
+4,652
+20,226% +$2.15M 0.59% 37
2023
Q1 		$10.6M Sell
23
-3,143
-99% -$1.5M 0.07% 125
2022
Q4 		$1.62M Buy
3,166
+3,154
+26,283% +$1.6M 0.53% 33
2022
Q3 		$5K Buy
+12
New +$5.74K 0.01% 276

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Mach-1 Financial Group's ELV Position: Q1 2024 in Review

Mach-1 Financial Group sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,764 shares — an estimated $832K sold.

Mach-1 Financial Group first reported a position in ELV in Q3 2022 and held it in 6 quarters. The position peaked at $10.6M in Q1 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Mach-1 Financial Group reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Mach-1 Financial Group sold 1,764 Elevance Health shares in Q1 2024, an estimated $832K.
  • Mach-1 Financial Group first reported a position in Elevance Health in Q3 2022 and held it in 6 quarters.
  • Mach-1 Financial Group's Elevance Health position peaked at $10.6M in Q1 2023.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Mach-1 Financial Group's 13F filing for Q1 2024, filed 10 May 2024.